Evaluation of Important Analytical Parameters of the Peptest Immunoassay that Limit its Use in Diagnosing Gastroesophageal Reflux Disease.


Journal

Journal of clinical gastroenterology
ISSN: 1539-2031
Titre abrégé: J Clin Gastroenterol
Pays: United States
ID NLM: 7910017

Informations de publication

Date de publication:
Historique:
pubmed: 5 6 2018
medline: 21 8 2020
entrez: 5 6 2018
Statut: ppublish

Résumé

To evaluate the analytical parameters of a lateral flow (LF) pepsin immunoassay (Peptest) and assess its suitability in the diagnostics of gastroesophageal reflux disease (GERD). Peptest is a noninvasive assay to analyze pepsin in saliva, intended for use in GERD diagnostics. Although commercialized, fundamental studies on its performance are missing. The assay therefore requires basic analytical parameter evaluation to assess its suitability in clinical practice. Assay reaction's time dependence, reader device repeatability, and individual LF devices and longitudinal pepsin concentration reproducibility in individual subjects was evaluated. Salivary pepsin was analyzed in 32 GERD patients with extraesophageal reflux symptoms and 13 healthy individuals. The assay's signal increase is not completed at the recommend readout time and continues to increase for another 25 minutes. The relative standard deviation of measurement was good when using the same LF device, ranging from 2.3% to 12.9%, but the reproducibility of 10 different individual LF devices was poor. The random error when analyzing the same saliva sample on 10 LF devices was as high as 36 ng/mL and this value is thus suggested as the positivity cut-off. Pepsin concentration in individual subjects during a 10-day period varied significantly. The sensitivity of the Peptest was 36.8% in the group with acid reflux and 23.1% in the group with weakly acid reflux. The specificity was 61.5%. The Peptest assay's sensitivity and specificity is low, the results are highly variable and it should not be used as a near-patient diagnostic method in primary care.

Sections du résumé

GOAL
To evaluate the analytical parameters of a lateral flow (LF) pepsin immunoassay (Peptest) and assess its suitability in the diagnostics of gastroesophageal reflux disease (GERD).
BACKGROUND
Peptest is a noninvasive assay to analyze pepsin in saliva, intended for use in GERD diagnostics. Although commercialized, fundamental studies on its performance are missing. The assay therefore requires basic analytical parameter evaluation to assess its suitability in clinical practice.
STUDY
Assay reaction's time dependence, reader device repeatability, and individual LF devices and longitudinal pepsin concentration reproducibility in individual subjects was evaluated. Salivary pepsin was analyzed in 32 GERD patients with extraesophageal reflux symptoms and 13 healthy individuals.
RESULTS
The assay's signal increase is not completed at the recommend readout time and continues to increase for another 25 minutes. The relative standard deviation of measurement was good when using the same LF device, ranging from 2.3% to 12.9%, but the reproducibility of 10 different individual LF devices was poor. The random error when analyzing the same saliva sample on 10 LF devices was as high as 36 ng/mL and this value is thus suggested as the positivity cut-off. Pepsin concentration in individual subjects during a 10-day period varied significantly. The sensitivity of the Peptest was 36.8% in the group with acid reflux and 23.1% in the group with weakly acid reflux. The specificity was 61.5%.
CONCLUSIONS
The Peptest assay's sensitivity and specificity is low, the results are highly variable and it should not be used as a near-patient diagnostic method in primary care.

Identifiants

pubmed: 29863588
doi: 10.1097/MCG.0000000000001066
doi:

Substances chimiques

Pepsin A EC 3.4.23.1

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-360

Auteurs

Jiří Dolina (J)

Internal Gastroenterology Department.

Štefan Konečný (Š)

Internal Gastroenterology Department.

Pavol Ďurč (P)

Department of Bioanalytical Instrumentation, CEITEC Masaryk University.
Department of Chemistry, Masaryk University, Brno, Czech Republic.

Júlia Lačná (J)

Department of Bioanalytical Instrumentation, CEITEC Masaryk University.
Department of Chemistry, Masaryk University, Brno, Czech Republic.

Michal Greguš (M)

Department of Bioanalytical Instrumentation, CEITEC Masaryk University.

František Foret (F)

Department of Bioanalytical Instrumentation, CEITEC Masaryk University.

Jana Skřičková (J)

Department of Pulmonary Diseases and Tuberculosis, University Hospital Brno and Faculty of Medicine, Masaryk University.

Martina Doubková (M)

Department of Pulmonary Diseases and Tuberculosis, University Hospital Brno and Faculty of Medicine, Masaryk University.

Dagmar Kindlová (D)

Department of Pulmonary Diseases and Tuberculosis, University Hospital Brno and Faculty of Medicine, Masaryk University.

Eva Pokojová (E)

Department of Pulmonary Diseases and Tuberculosis, University Hospital Brno and Faculty of Medicine, Masaryk University.

Petr Kubáň (P)

Department of Bioanalytical Instrumentation, CEITEC Masaryk University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH